Background and study aims A novel technique for Barrett's esophagus (BE) ablation, termed
hybrid APC, has recently been developed. The aims of this US pilot study were to evaluate …

Results A total of 17 patients with biopsy proven NDBE 58.8%, LGD 17.6%, HGD 23.5%
underwent 24 treatments with Hybrid APC. Average age was 69.2 years, Male 83.3 …

Methods: Patients with biopsy proven BE referred to our tertiary care center for mucosal
ablation were recruited. Both treatment-naive and patients previously treated were included …

Background: Five to ten percent of all patients undergoing radiofrequency ablation (RFA),
which is the most established technique for Barrett's esophagus (BE) ablation-develop …

Methods A literature search from January 2000 to November 2022 was done for studies
analyzing the outcome of APC in BE. The primary outcomes were clearance rate of intestinal …

Results In a total of 12 patients with short segment of BE (< 3cm) complete macroscopic BE
ablation was achieved after a mean of 2.5 (range 1-4) treatment sessions and the rate of …

Methods This multicenter study in nine endoscopy centers in Europe included patients with
biopsy proven neoplastic BE. Therapy consisted of either exclusive ablation in patients …

Background Focal ablation for Barrett's Esophagus (BE) has traditionally been performed
with the focal radiofrequency ablation (RFA) catheter. However, this is a relatively expensive …

Introduction Radiofrequency ablation (RFA) and hybrid argon plasma coagulation (H-APC)
are established thermal ablation techniques for eradicating Barrett's esophagus after …

Background This study evaluated the impact of power setting and proton pump inhibitor
(PPI) dose on efficacy and safety of argon plasma coagulation (APC) of Barrett's esophagus …